Skip to main content

GOLDMAN SACHS GROUP INC

Position in RLAY — Relay Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in RLAY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$63,776,795
+$38,485,279 QoQ
Shares Held
3,408,701
+34.1% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RLAY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. RLAY ranks #55 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RLAY

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,776,795 3,408,701
2026-03-31 $25,291,516 2,541,861
2025-12-31 $15,732,503 1,859,634
2025-09-30 $9,755,506 1,868,871
2025-06-30 $6,695,676 1,935,167
2025-03-31 $5,444,345 2,077,995
2024-12-31 $11,148,591 2,705,969
2024-09-30 $13,986,291 1,975,465
2024-06-30 $9,679,056 1,484,518
2024-03-31 $14,634,127 1,763,148
2023-12-31 $10,827,090 983,387
2023-09-30 $7,498,397 891,605
2023-06-30 $16,195,504 1,289,451
2023-03-31 $23,043,159 1,399,099
2022-12-31 $19,024,819 1,273,415
2022-09-30 $31,906,397 1,426,303
2022-06-30 $16,076,365 959,783
2022-03-31 $9,002,075 300,771
2021-12-31 $13,604,559 443,001
2021-09-30 $5,031,588 159,581
2021-06-30 $7,198,642 196,738
2021-03-31 $33,401,533 966,200
2020-12-31 $28,643,732 689,214
2020-09-30 $4,529,829 106,359